(1.13%) 5 105.27 points
(0.52%) 38 284 points
(2.03%) 15 929 points
(0.25%) $83.78
(-1.95%) $1.606
(0.38%) $2 351.50
(0.04%) $27.36
(0.29%) $923.15
(0.32%) $0.935
(0.68%) $11.03
(0.12%) $0.800
(-0.33%) $91.87
Live Chart Being Loaded With Signals
Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system...
Stats | |
---|---|
Today's Volume | 50 199.00 |
Average Volume | 31 231.00 |
Market Cap | 464.62M |
EPS | SEK0 ( 2024-02-22 ) |
Next earnings date | ( SEK0 ) 2024-05-10 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -9.65 |
ATR14 | SEK0.0720 (0.82%) |
Initiator Pharma A/S Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Initiator Pharma A/S Correlation - Currency/Commodity
Initiator Pharma A/S Financials
Annual | 2023 |
Revenue: | SEK0 |
Gross Profit: | SEK-23 412.00 (0.00 %) |
EPS: | SEK-0.440 |
FY | 2023 |
Revenue: | SEK0 |
Gross Profit: | SEK-23 412.00 (0.00 %) |
EPS: | SEK-0.440 |
FY | 2022 |
Revenue: | SEK0 |
Gross Profit: | SEK-38 425.00 (0.00 %) |
EPS: | SEK-0.720 |
FY | 2021 |
Revenue: | SEK0.00 |
Gross Profit: | SEK-21.63M (0.00 %) |
EPS: | SEK-0.531 |
Financial Reports:
No articles found.
Initiator Pharma A/S
Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. It develops IP2018, a monoamine reuptake inhibitor for the treatment of psychogenic erectile dysfunction; IPED2015 to treat patients suffering from organic erectile dysfunction; and IPTN2021 for targeting an orphan drug indication in severe neuropathic pain. The company's pre-clinical stage candidates include IPNP2015 for the treatment of chronic pain; and IPDP2015 for depression. Initiator Pharma A/S was incorporated in 2016 and is headquartered in Copenhagen, Denmark.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators